Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Disorder in Complete Remission in Response to Treatment”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableLooking for participantsNCT05416164
What this trial is testing

DESCARTES: De-ESCAlation of RadioTherapy in Patients With Pathologic Complete rESponse to Neoadjuvant Systemic Therapy

Who this might be right for
Breast Cancer
The Netherlands Cancer Institute 595
Testing effectiveness (Phase 2)Study completedNCT00717405
What this trial is testing

Avastin (Bevacizumab) Plus Herceptin (Trastuzumab) in Patients With Primary Inflammatory HER2-Positive Breast Cancer.

Who this might be right for
Breast Cancer
Hoffmann-La Roche 52
Not applicableStudy completedNCT06630481
What this trial is testing

Long-term Survival Outcomes According to the Pathologic Response After Neoadjuvant Treatment in PDAC and the Fate of the Patients with Good CAP Grade

Who this might be right for
Pancreatic CancerNeoadjuvant TherapyPathological Complete Response
Seoul National University Hospital 462
Testing effectiveness (Phase 2)Looking for participantsNCT05563012
What this trial is testing

Short-course Radiotherapy Combined With Neoadjuvant Chemotherapy and PD-1 Inhibitor in the Treatment of Locally Advanced Gastric Adenocarcinoma

Who this might be right for
Disorder in Complete Remission in Response to Treatment
Renmin Hospital of Wuhan University 29
Large-scale testing (Phase 3)Active Not RecruitingNCT04335669
What this trial is testing

NordicTrip, a Translational Study of Preoperative Chemotherapy in TNBC

Who this might be right for
Breast CancerTriple Negative Breast Neoplasms
Lund University Hospital 325
Not applicableStudy completedNCT04909554
What this trial is testing

MRI-based Approaches for Multi-parametric Model to Early Predict Pathological Complete Response to Neoadjuvant Therapy in Breast Cancer

Who this might be right for
Breast Cancer
Guangdong Provincial People's Hospital 301
Large-scale testing (Phase 3)Active Not RecruitingNCT03522246
What this trial is testing

A Study in Ovarian Cancer Patients Evaluating Rucaparib and Nivolumab as Maintenance Treatment Following Response to Front-Line Platinum-Based Chemotherapy

Who this might be right for
Epithelial Ovarian CancerPrimary PeritonealFallopian Tube Cancer+4 more
pharmaand GmbH 1,097
Post-approval studies (Phase 4)Study completedNCT01206764
What this trial is testing

A Trial of Everolimis in Patients With Advanced Renal Cell Carcinoma.

Who this might be right for
Renal Cell Carcinoma
Novartis Pharmaceuticals 143
Testing effectiveness (Phase 2)Study completedNCT01818063
What this trial is testing

Carboplatin and Combination Chemotherapy With or Without Veliparib in Treating Patients With Stage IIB-IIIC Breast Cancer

Who this might be right for
Estrogen Receptor-negative Breast CancerHER2-negative Breast CancerProgesterone Receptor-negative Breast Cancer+5 more
Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University 9
Large-scale testing (Phase 3)Active Not RecruitingNCT05610163
What this trial is testing

Testing the Addition of an Anti-Cancer Drug, Irinotecan, to the Standard Chemotherapy Treatment (FOLFOX) After Long-Course Radiation Therapy for Advanced-Stage Rectal Cancers to Improve the Rate of Complete Response and Long-Term Rates of Organ Preservation and Continuing Response

Who this might be right for
Stage II Rectal Cancer AJCC v8Stage III Rectal Cancer AJCC v8Locally Advanced Rectal Adenocarcinoma
Alliance for Clinical Trials in Oncology 760
Not applicableStudy completedNCT06996301
What this trial is testing

Clinical Utility of a PCR Compared to Culture and Sensitivity Testing for the Management of cUTI in Adults.

Who this might be right for
Urinary Tract Infection ComplicatedUrinary Tract Infection (cUTI)Urinary Tract Infection (Diagnosis)
Doc Lab Inc 773
Not applicableStudy completedNCT00562458
What this trial is testing

Non-interventional Study to Evaluate Arimidex in Postmenopausal Women With Advanced Breast Cancer

Who this might be right for
Advanced Breast Cancer
AstraZeneca 200
Not applicableLooking for participantsNCT07006012
What this trial is testing

RGL-305+ Lymphoma + Exploratory Clinical Study

Who this might be right for
Lymphoma Patients With Complete Response (CR) or Partial Response (PR) After Standard Treatment Had a Positive Minimal Residual Lesion (MRD)
Fudan University 12
Testing effectiveness (Phase 2)Study completedNCT00093639
What this trial is testing

Everolimus and Imatinib Mesylate in Treating Patients With Chronic Phase Chronic Myelogenous Leukemia Who Are Not in Complete Cytogenetic Remission After Previous Imatinib Mesylate

Who this might be right for
Leukemia
Novartis Pharmaceuticals
Testing effectiveness (Phase 2)Active Not RecruitingNCT07421141
What this trial is testing

De-escalation of Neoadjuvant Treatment (Paclitaxel + HP) in Early HER2+ Breast Cancer

Who this might be right for
Breast CancerHER2-positive Breast CancerEarly Breast Cancer
National Medical Research Radiological Centre of the Ministry of Health of Russia 186
Testing effectiveness (Phase 2)Study completedNCT00005780
What this trial is testing

Chemotherapy Plus Vaccination to Treat Mantle Cell Lymphoma

Who this might be right for
Mantle Cell LymphomaLymphoma, Mantle Cell
National Cancer Institute (NCI) 26
Testing effectiveness (Phase 2)UnknownNCT00722930
What this trial is testing

Consolidation Treatment With Y90-Ibritumomab Tiuxetan After R-CHOP Induction in High Risk Patients According to Follicular Lymphoma International Prognostic Index (FLIPI) With Follicular Lymphoma

Who this might be right for
Follicular Lymphoma
Grupo Oncológico para el Tratamiento y el Estudio de los Linfomas 38
Not applicableStudy completedNCT03601689
What this trial is testing

Predictive Factors of Disease-free Survival After Complete Pathological Response to Neoadjuvant Radiotherapy in Rectal Adenocarcinoma

Who this might be right for
Rectal Neoplasms
Moroccan Society of Surgery 84
Large-scale testing (Phase 3)Looking for participantsNCT06498635
What this trial is testing

Immunotherapy After Surgery for People Who Have No Remaining Cancer Cells After Standard Treatment for Early-Stage Non-Small Cell Lung Cancer, INSIGHT Trial

Who this might be right for
Lung Non-Small Cell CarcinomaStage II Lung Cancer AJCC v8Stage IIIA Lung Cancer AJCC v8+1 more
National Cancer Institute (NCI) 306
Testing effectiveness (Phase 2)Active Not RecruitingNCT04722172
What this trial is testing

A Study on Limiting Treatment Time With Acalabrutinib Combined With Obinutuzumab in People With CLL or SLL

Who this might be right for
Chronic Lymphocytic LeukemiaSmall Lymphocytic Lymphoma
Memorial Sloan Kettering Cancer Center 55
Next Page